Corvus Pharmaceuticals, Inc. (CRVS) vs Odyssey Therapeutics, Inc. (ODTX)
A side-by-side comparison of Corvus Pharmaceuticals, Inc. and Odyssey Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRVS
Corvus Pharmaceuticals, Inc.
$10.31HealthcareDelayed quote: Oct 6, 2026, 2:00 PM EDT
ODTX
Odyssey Therapeutics, Inc.
$18.77HealthcareDelayed quote: Oct 6, 2026, 2:00 PM EDT
Total return — CRVS vs ODTX
growth of $100 · dividends reinvested · last 1yCRVS -30.5% (-30.5%/yr)ODTX +26.9% (+26.9%/yr)ODTX compounded faster over this window
CRVS ODTX
CRVS vs ODTX: by the numbers
- •ODTX is the larger company ($902M vs $867M market cap).
- •Both run net losses; CRVS's is the smaller (0.00% vs -4994.86% net margin).
Metrics side by side
Valuation
| Metric | CRVS | ODTX |
|---|---|---|
| P/B ratio | 3.85 | 2.14 |
Profitability
| Metric | CRVS | ODTX |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -5415.19% |
| Net margin | 0.00% | -4994.86% |
| ROE | -24.02% | N/A |
| ROIC | -25.25% | -66.23% |
Growth (annualized)
| Metric | CRVS | ODTX |
|---|---|---|
| Total return CAGR (5Y) | 17.88% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.